EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hederagenin Ameliorates Inferior Vena Cava Thrombosis via Modulating the MDM2-p53 Axis to Concurrently Suppress NF-κB-Mediated Endothelial Inflammation, Oxidative Stress, and Platelet Activation

Tianzi Wang, Jinglei Huang, Xingyue Song, Yan Zhang, Wenling Shi, Lihan Song, Youqing Cheng, Zhihao Chen, Xiaofan Zhang, Wei Xie, Guoqing Wan

Antioxidants · 06.11.2026 · 15 (11) · 1437

DOI: 10.3390/antiox15111437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 06.11.2026. Verfasst von Tianzi Wang und 10 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Key Laboratory of Molecular Imaging.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The aim of this study was to investigate the antioxidant and anti-inflammatory potential of hederagenin (HD), a natural bioactive compound from the Sparganii Rhizoma–Curcumae Rhizoma herb pair, in deep vein thrombosis (DVT) and to elucidate its mechanism via the MDM2–p53 axis.

Methods

A rat DVT model induced by inferior vena cava stenosis and an oxygen–glucose deprivation (OGD)-stimulated EA.hy926 endothelial cell model were established. Rats received HD (12.5, 25, 50 mg/kg) or heparin. Thrombus weight, coagulation, histopathology, immunofluorescence, immunohistochemistry, and Western blot were assessed. Inflammatory cytokines (TNF-α, IL-1β, CRP) and oxidative stress markers (SOD, MDA) were measured. Platelet aggregation was induced by ADP, arachidonic acid, and thrombin. Network pharmacology, molecular docking, and molecular dynamics simulations were performed.

Results

HD dose-dependently reduced thrombus weight, improved coagulation, and downregulated tissue factor and von Willebrand factor. HD decreased TNF-α, IL-1β, CRP, and MDA levels and restored SOD activity, demonstrating antioxidant and anti-inflammatory effects. Network pharmacology identified MDM2 as a core target. Molecular docking showed favorable HD–MDM2 binding (−8.2 kcal/mol), and 100 ns molecular dynamics confirmed complex stability. HD downregulated MDM2, upregulated p53/p-p53, and suppressed NF-κB p65 phosphorylation and acetylation in IVC tissues and OGD-stimulated cells. HD also inhibited platelet aggregation, reduced vWF release, and downregulated CD41/CD61.

Conclusions

HD, a natural bioactive compound, attenuates DVT through antioxidant and anti-inflammatory mechanisms by modulating the MDM2–p53 axis, concurrently suppressing endothelial inflammation, oxidative stress, and platelet activation. It is a promising dual-acting candidate for DVT therapy.

Förderung

  • Shanghai Key Laboratory of Molecular Imaging

Zitieren

APA

Wang, T., Huang, J., Song, X., Zhang, Y., Shi, W., Song, L., Cheng, Y., Chen, Z., Zhang, X., Xie, W., & Wan, G. (2026). Hederagenin Ameliorates Inferior Vena Cava Thrombosis via Modulating the MDM2-p53 Axis to Concurrently Suppress NF-κB-Mediated Endothelial Inflammation, Oxidative Stress, and Platelet Activation. Antioxidants, 15(11), 1437. https://doi.org/10.3390/antiox15111437

Vancouver

Wang T, Huang J, Song X, Zhang Y, Shi W, Song L, et al. Hederagenin Ameliorates Inferior Vena Cava Thrombosis via Modulating the MDM2-p53 Axis to Concurrently Suppress NF-κB-Mediated Endothelial Inflammation, Oxidative Stress, and Platelet Activation. Antioxidants. 2026;15(11):1437. doi:10.3390/antiox15111437

BibTeX
@article{Wang2026,
  author = {Wang, Tianzi and Huang, Jinglei and Song, Xingyue and Zhang, Yan and Shi, Wenling and Song, Lihan and Cheng, Youqing and Chen, Zhihao and Zhang, Xiaofan and Xie, Wei and Wan, Guoqing},
  title = {Hederagenin Ameliorates Inferior Vena Cava Thrombosis via Modulating the MDM2-p53 Axis to Concurrently Suppress NF-κB-Mediated Endothelial Inflammation, Oxidative Stress, and Platelet Activation},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1437},
  doi = {10.3390/antiox15111437}
}
Kostenlos starten →